Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioClinica Inks $30 Million in eClinical Contracts

Published: Saturday, March 29, 2014
Last Updated: Saturday, March 29, 2014
Bookmark and Share
Multi-year signings for enterprise-wide technology and support.

BioClinica®, Inc. has announced that it has recently penned $30 million in multi-year contract renewals with two major pharmaceutical companies.

Collectively these engagements encompass cloud-based technologies and professional services and training across BioClinica's full eClinical product suite: OnPoint CTMS, Express EDC, Trident IRT, and clinical supplies Optimizer.

Under the contracts BioClinica will support several hundred clinical studies annually through 2017. "Large back-to-back awards like this demonstrate that BioClinica lives up to the high expectations of top tier pharma," BioClinica's President of eClinical Solutions Peter Benton said. "BioClinica technologies accommodate the high volume of studies conducted by large life science companies and enable sponsors to drive their research forward."

The contracts extend partnering arrangements that originated a decade ago. Since then, BioClinica has supported the two organizations in clinical trials across thousands of investigative sites worldwide.

BioClinica technologies create efficiencies that compress the clinical investigation timeline. "In our experience with one of these customers we have reduced study start-up time to two weeks on most of their trials and have cut close-out time to just one week," according to Benton. "Employing standards and electronic forms libraries also brings speed and efficiency, which becomes especially apparent to sponsors like this who are running high volume studies."

In the first agreement, BioClinica will provide resources and subject matter expertise in clinical supply chain distribution systems and processes that extend to several thousand investigators using Interactive Response Technology (IRT) worldwide.

In the second agreement, BioClinica's easy-to-use OnPoint CTMS and Express EDC technologies will provide the foundation for their clinical operations.

Data management, study design, and related professional services that support clinical studies globally will also be provided.

Enterprise-wide implementation of cloud-based technologies is currently underway with BioClinica employees contracted to be embedded within each organization, augmenting the pharmaceutical companies' internal resources.

BioClinica will hold its Global User Conference on May 5-7 in Philadelphia, Pennsylvania where the latest features of its full eClinical product lineup will be demonstrated. Customers may register online for the 2014 BioClinica User Conference.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioClinica Launches New eClinical CRO Partner Alliance Program
Access to eClinical knowledge, best practices and financial benefits drive CRO success.
Saturday, October 24, 2015
BioClinica Acquires Synowledge
Adds capabilities in pharmacovigilance and regulatory technology, data analysis and business process management.
Friday, September 25, 2015
BioClinica Expands Operational Capabilities, Opens New European Offices
Combined space of 1,400 square meters to support clinical trial services.
Thursday, July 02, 2015
BioClinica and Kinapse Partner to Accelerate RBM Implementation
Bolsters adoption of compass intelligent monitoring solution.
Thursday, May 28, 2015
BioClinica Names Mukhtar Ahmed as eClinical President
Technology and industry leader to head eClinical business unit.
Friday, April 24, 2015
BioClinica Opens Research Triangle Park Office
Sponsors and CRO strategic partners drive RTP expansion.
Friday, March 27, 2015
BioClinica Grows eClinical Results in Europe
Expands presence to meet demand for EDC, CTMS and IRT Technologies.
Friday, February 07, 2014
BioClinica and Rutgers University Announce Research Project Results
Scientific Partnership Aims to Expand Automation of Clinical Trial Image Data Analysis
Saturday, November 23, 2013
Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
HIV Structure Stabilized
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Four Newly-Identified Genes Could Improve Rice
A Japanese research team have applied a method used in human genetic analysis to rice and rapidly discovered four new genes that are potentially significant for agriculture. These findings could influence crop breeding and help combat food shortages caused by a growing population.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Antibodies To Dengue May Alter Course Of Zika Virus Infection
Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!